Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Jul 16;18(3):676–683.e3. doi: 10.1016/j.cgh.2019.07.017

Figure 3:

Figure 3:

Methylated DNA markers (MDM) assayed from pancreatic juice discriminate pancreatic cancer and IPMN with high grade dysplasia from healthy and diseased controls. ROC curves plotted (Numerical areas under the curve (AUCs) with 95% confidence shown within the figures). A. AUCs of 3-MDM panel and individual MDMs within panel. B. AUCs of MDM panel: best-fit model in comparison to the cross-validated model.